IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (841)	5/12/1997 10:05:00 PM
From: I. Luttichuys	of 1762

This summer I am going to be working on a study in San Francisco addressing the physician's need for information on what patients consider to be effecacious CA therapy. Preliminary results show, as one might expect, that they find tumour mass reduction to be secondary to as much preservation of a reasonable lifestyle during therapy as possible. The preliminary results have generated a great deal of interest among oncologists as, believe it or not, such a study has not yet been done. By great coincidence the study subjects are... you guessed it... non-Hodgkin's lymphoma patients. I have posted about this before but it is something worth repeating as it indicates that IDEC's C2B8 looks to be coming to market at a time when not only patients are looking for this kind of therapy but, when physicians will be eagerly seeking such a therapy as well. BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next